Seeking Alpha

More on MAKO Surgical (MAKO): Q3 beats consensus on both EPS and revenue, but the company lowers...

More on MAKO Surgical (MAKO): Q3 beats consensus on both EPS and revenue, but the company lowers its guidance for MAKOplasty procedures in Q4, based on the total procedures performed in the first three quarters of FY12 and the unknown net effect of Hurricane Sandy. It now expects to perform between 10,200 to 10,600 procedures, down from prior guidance of 11K to 12K. FY12 annual guidance of 42 - 48 expected RIO system sales remains unchanged. Shares -1.4% AH.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector